1209 related articles for article (PubMed ID: 12604686)
1. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
[TBL] [Abstract][Full Text] [Related]
2. Effects of the second-generation synthetic lipid A analogue E5564 on responses to endotoxin in [corrected] equine whole blood and monocytes.
Figueiredo MD; Moore JN; Vandenplas ML; Sun WC; Murray TF
Am J Vet Res; 2008 Jun; 69(6):796-803. PubMed ID: 18518661
[TBL] [Abstract][Full Text] [Related]
3. E5564 (Eritoran) inhibits lipopolysaccharide-induced cytokine production in human blood monocytes.
Czeslick E; Struppert A; Simm A; Sablotzki A
Inflamm Res; 2006 Nov; 55(11):511-5. PubMed ID: 17122970
[TBL] [Abstract][Full Text] [Related]
4. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
5. Moesin: a potential LPS receptor on human monocytes.
Amar S; Oyaisu K; Li L; Van Dyke T
J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of in vivo and ex vivo response to endotoxin by E5564, a synthetic lipid A analogue.
Rossignol DP; Lynn M
J Endotoxin Res; 2002; 8(6):483-8. PubMed ID: 12697095
[TBL] [Abstract][Full Text] [Related]
7. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation.
Liu Y; Wang Y; Yamakuchi M; Isowaki S; Nagata E; Kanmura Y; Kitajima I; Maruyama I
Infect Immun; 2001 May; 69(5):2788-96. PubMed ID: 11292690
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of endotoxin activity by muramyldipeptide.
Takada H; Yokoyama S; Yang S
J Endotoxin Res; 2002; 8(5):337-42. PubMed ID: 12537692
[TBL] [Abstract][Full Text] [Related]
10. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
[TBL] [Abstract][Full Text] [Related]
11. Expression and involvement of Toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis.
Mirlashari MR; Lyberg T
Med Sci Monit; 2003 Aug; 9(8):BR316-24. PubMed ID: 12942028
[TBL] [Abstract][Full Text] [Related]
12. Blocking of responses to endotoxin by E5564 in healthy volunteers with experimental endotoxemia.
Lynn M; Rossignol DP; Wheeler JL; Kao RJ; Perdomo CA; Noveck R; Vargas R; D'Angelo T; Gotzkowsky S; McMahon FG
J Infect Dis; 2003 Feb; 187(4):631-9. PubMed ID: 12599080
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
[TBL] [Abstract][Full Text] [Related]
14. Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling.
Shinohara H; Inoue A; Toyama-Sorimachi N; Nagai Y; Yasuda T; Suzuki H; Horai R; Iwakura Y; Yamamoto T; Karasuyama H; Miyake K; Yamanashi Y
J Exp Med; 2005 Feb; 201(3):333-9. PubMed ID: 15699069
[TBL] [Abstract][Full Text] [Related]
15. Identification of meningococcal LPS as a major monocyte activator in IL-10 depleted shock plasmas and CSF by blocking the CD14-TLR4 receptor complex.
Bjerre A; Brusletto B; Øvstebø R; Joø GB; Kierulf P; Brandtzaeg P
J Endotoxin Res; 2003; 9(3):155-63. PubMed ID: 12831456
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endotoxin or lipid A-induced tumor necrosis factor production by synthetic lipid A partial structures in human peripheral blood mononuclear cells.
Wang MH; Flad HD; Feist W; Musehold J; Kusumoto S; Brade H; Gerdes J; Rietschel HT; Ulmer AJ
Lymphokine Cytokine Res; 1992 Feb; 11(1):23-31. PubMed ID: 1576244
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells.
Paik YH; Schwabe RF; Bataller R; Russo MP; Jobin C; Brenner DA
Hepatology; 2003 May; 37(5):1043-55. PubMed ID: 12717385
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin-induced chemokine expression in murine peritoneal mesothelial cells: the role of toll-like receptor 4.
Kato S; Yuzawa Y; Tsuboi N; Maruyama S; Morita Y; Matsuguchi T; Matsuo S
J Am Soc Nephrol; 2004 May; 15(5):1289-99. PubMed ID: 15100369
[TBL] [Abstract][Full Text] [Related]
19. A novel lipid A from Halomonas magadiensis inhibits enteric LPS-induced human monocyte activation.
Ialenti A; Di Meglio P; Grassia G; Maffia P; Di Rosa M; Lanzetta R; Molinaro A; Silipo A; Grant W; Ianaro A
Eur J Immunol; 2006 Feb; 36(2):354-60. PubMed ID: 16365914
[TBL] [Abstract][Full Text] [Related]
20. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Ratz CA; Johnston JW; Haseman JR; Gray BH; Dunn DL
J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
